About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Tennessee | 18,964 Studies Near You

Clinical TrialsTennessee

Clinical Trials in Tennessee

Discover 18,964 clinical trials near Tennessee. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 3521-3540 of 18,964 trials

CompletedAn Extension Trial of Inclisiran in Participants With Cardiovascular Disease and High CholesterolThis clinical study was designed to assess the efficacy, safety, and tolerability of long-term dosing of inclisiran and evolocumab given as subcutaneous injections in participants…NCT03060577·Jacksonville, Florida and 51 others

Find Trials by Condition in Tennessee

Breast Cancerin Tennessee Lung Cancerin Tennessee Prostate Cancerin Tennessee Colorectal Cancerin Tennessee Melanomain Tennessee Leukemiain Tennessee Lymphomain Tennessee Pancreatic Cancerin Tennessee Ovarian Cancerin Tennessee Brain Cancerin Tennessee

Data from ClinicalTrials.govTerms

Not yet recruitingEfficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS)The main purpose of this study, performed under Master Protocol J4M-MC-PWMP (NCT06672549), is to evaluate the efficacy, safety, and pharmacokinetics of tirzepatide as an addition…NCT07817875·Tucson, Arizona and 83 others

CompletedNatural History of Rett Syndrome & Related DisordersThe purpose of this study is to advance understanding of the natural history of Rett syndrome (RTT), MECP2-duplication disorder (MECP2 Dup), CDKL5, FOXG1, and individuals with…NCT02738281·Birmingham, Alabama and 13 others

CompletedStudy to Assess in Home Use of Evolocumab (AMG 145) Administration Using Either an Automated Mini-doser or a Prefilled Autoinjector/PenThe primary objective of this study was to assess users' ability to administer a full dose of evolocumab in a home-use setting using either an automated mini-doser (AMD) or…NCT01879319·Phoenix, Arizona and 26 others

CompletedROMAN: Phase 3 Trial Investigating the Effects of GC4419 on Radiation Induced Oral Mucositis in Head/Neck Cancer PatientsThe purpose of the phase 3, clinical study is to determine if GC4419 (avasopasem manganese) administered prior to intensity-modulated radiation therapy (IMRT) reduces the severity…NCT03689712·Gilbert, Arizona and 96 others

CompletedA Study of RGX-202-01 (Ompenaclid) as Combination Therapy in RAS Mutant Advanced Colorectal CancerThis is a Phase 1 study currently evaluating PO administered ompenaclid in combination with FOLFIRI and bevacizumab in patients with advanced (i.e., locally advanced and…NCT03597581·Prescott Valley, Arizona and 16 others

CompletedA Phase 3, Vehicle-controlled Efficacy and Safety Study of IDP-123 Lotion in the Treatment of Acne Vulgaris (302)This is a multi-center, randomized, double-blind, vehicle-controlled, 12-week study designed to assess the safety, efficacy, and tolerability of IDP-123 Lotion in comparison with…NCT03168334·Mobile, Alabama and 44 others

CompletedEvaluation of Effectiveness of Two Dosing Regimens of Fostamatinib Compared to Placebo in Patients With Rheumatoid Arthritis (RA) Who Are Taking Disease Modifying Anti-rheumatic Drug (DMARD) But Not Responding.The purpose of the study is to evaluate the effectiveness of two dosing regimens of fostamatinib compared to placebo, in patients with rheumatoid arthritis (RA) who are taking…NCT01197534·Birmingham, Alabama and 148 others

CompletedAdaptive Interventions for Minimally Verbal Children With ASD in the CommunityAdaptive Interventions for Minimally Verbal Children with ASD in the Community, seeks support to construct an adaptive intervention that utilizes two efficacious interventions…NCT01751698·Los Angeles, California and 3 others

CompletedPhase 1/2 Dose Finding and Safety Study of Ibrutinib in Pediatric Subjects With Chronic Graft Versus Host Disease (cGVHD)Dose Finding and Safety Study of Ibrutinib in Pediatric Subjects with Chronic Graft Versus Host Disease (cGVHD)NCT03790332·Duarte, California and 47 others

CompletedLong-term Safety Study of Glycopyrronium in Subjects With Primary Axillary HyperhidrosisThis is an open-label, long-term safety study of glycopyrronium topical wipes, enrolling up to 660 subjects with primary axillary hyperhidrosis who participated in either the…NCT02553798·Mobile, Alabama and 47 others

TerminatedStudy of INCA 0186 in Subjects With Advanced Solid TumorsThis is an open-label, nonrandomized, multicenter, dose escalation, and dose expansion first-in human (FIH) Phase 1 study to determine the safety, tolerability, PK…NCT04989387·Los Angeles, California and 31 others

TerminatedG-PLUS (GALLANT, GALLEX and ARMOR - Post Treatment Follow-up Study)This is a long-term safety follow-up study to assess the post-treatment safety, at 12 and 24 months, in patients with type 2 diabetes after participation in the phaseII/III…NCT00255645·Birmingham, Alabama and 542 others

CompletedA Study LY2228820 for Recurrent Ovarian CancerA study for women with ovarian cancer that has returned at least 6 months after platinum-based chemotherapy.NCT01663857·Phoenix, Arizona and 29 others

CompletedPhase I/II Trial of Tivantinib With FOLFOX for the Treatment of Advanced Solid Tumors and Previously Untreated Metastatic Adenocarcinoma of the Distal Esophagus, Gastroesophageal Junction or StomachThis study is a Phase I/II trial of Tivantinib plus FOLFOX for the treatment of patients with advanced solid tumors.NCT01611857·New Haven, Connecticut and 8 others

CompletedRadiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder CancerRATIONALE: Radiation therapy uses x-rays to damage tumor cells. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00003930·Birmingham, Alabama and 228 others

TerminatedTreatment With Combination Chemotherapy for Relapsed or Refractory Acute Lymphoblastic LeukemiaLeukemia cells grow and divide fast and out of control. In normal cells, certain proteins called CDK4 and CDK6 control cell growth.NCT03515200·Memphis, Tennessee

CompletedA Study to Characterize the Biodistribution of 124I-Labeled AT-03 in Patients With Systemic AmyloidosisThis is a single center Phase 1 study is to evaluate the biodistribution of radiolabeled AT-03 in patients with systemic amyloidosis.NCT05201911·Knoxville, Tennessee

CompletedTREND-HD - A Trial of Ethyl-EPA (Miraxion™) in Treating Mild to Moderate Huntington's DiseaseThis study is designed to determine the effect of 2 gram/day of ethyl-EPA on motor (movement) signs and symptoms of Huntington disease.NCT00146211·Birmingham, Alabama and 40 others

CompletedValidation of a Mobile Phone Based on EPRO Tool in Subjects With Systemic Lupus ErythematosusSystemic lupus erythematosus (SLE) may involve a variety of organ systems expressed differently from patient to patient, and so can be difficult to characterize clinically.NCT03142711·Atlanta, Georgia and 9 others

PreviousPage 177 of 949Next

Diabetes

in Tennessee

Heart Diseasein Tennessee